By inspecting the body’s immune response at a molecular level, a research team has developed a new way to test patients for COVID-19. Their method can potentially catch infections a matter of hours after exposure — far earlier than current COVID-19 tests can detect the virus — with near-perfect accuracy. The team describes their innovation, which is still in the early stages of development, in the February 27 issue of Cell Reports Methods.